Metraipolis › archive › dc_cc2d675c1a97

Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection — Europe PMC PMID:42104727

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42104727
DOI
10.1002/ame2.70211
License (as archived)
solo-consultazione
Archived
2026-11-02T12:52:58.626Z
SHA-256 of the archived text
0faef5f6abd34fc8e479b21f02f24f46b7cda52ed971e30954101bed1099d868
Stable URL of this page
https://metraipolis.com/documento/dc_cc2d675c1a97

How to cite

Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection — Europe PMC PMID:42104727 — Europe PMC (en), https://europepmc.org/article/MED/42104727 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_cc2d675c1a97 (Metraipolis archive dc_cc2d675c1a97, sha256 0faef5f6abd34fc8e479b21f02f24f46b7cda52ed971e30954101bed1099d868)
BibTeX
@misc{dccc2d675c1a97,
  title = {Stem cell-based therapies for type 1 diabetes: Progress in differentiation, clinical translation, and immune protection — Europe PMC PMID:42104727},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42104727},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_cc2d675c1a97; sha256 0faef5f6abd34fc8e479b21f02f24f46b7cda52ed971e30954101bed1099d868},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42104727. Agents can read the archived copy with the MCP tool read_document.